129 – Repurposing the Fda Approved Drug Pyrvinium Pamoate to Target Hur in Pancreatic Ductal Adenocarcinoma

@inproceedings{Schultz2019129R,
  title={129 – Repurposing the Fda Approved Drug Pyrvinium Pamoate to Target Hur in Pancreatic Ductal Adenocarcinoma},
  author={Christopher G. Schultz and Teena Dhir and Alex O. Haber and Wei Jiang and Saswati N Chand and Brown Samantha and Emanuel F. Petricoin and Charles J Yeo and Jonathan R. Brody},
  year={2019}
}

Topics from this paper.

Similar Papers

Loading similar papers…